| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 05/05/2026 | ±3.1% | +9.6% | under-priced |
| 02/17/2026 | ±7.0% | -1.5% | over-priced |
| 10/28/2025 | ±2.6% | +0.3% | over-priced |
| 07/22/2025 | ±2.9% | +17.9% | under-priced |
| 05/06/2025 | ±3.2% | -4.0% | under-priced |
| 02/13/2025 | ±4.1% | -0.9% | over-priced |
| 10/31/2024 | ±3.4% | -4.7% | under-priced |
| 07/22/2024 | ±2.8% | +9.2% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.61 | $4.2B | $274M |
| Q4 FY2025 | — | $4.4B | $514M |
| Q3 FY2025 | $1.93 | $4.1B | $331M |
| Q2 FY2025 | $1.54 | $4.0B | $266M |
IQV (IQV) reports in 6 days, with the next report estimated for 11/02/2026. Across the last 8 reports, options priced an average ±3.6% earnings move while the stock actually moved 6.0% on average — the market has been roughly fair on IQV's earnings risk. Fundamentals into the print: EPS up 15.0% year-over-year, revenue up 8.4%. QuantLogix's live 5-factor engine currently reads IQV as a buy at 92/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →